Passive smoking exposure is associated with increased risk of COPD in never smokers

Chest

Volumn 145, Issue 6, 2014, Pages 1298-1304

  Hagstad, Stig ^a,b   Bjerg, Anders ^a,b   Ekerljung, Linda ^a   Backman, Helena ^b   Lindberg, Anne ^b,c   Ron̈mark, Eva ^b,c   Lundbac̈k, Bo ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SUNDERBY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TOBACCO SMOKE;

ADULT; AGED; ARTICLE; BRONCHOSPIROGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PASSIVE SMOKING; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SPIROMETRY; STRUCTURED INTERVIEW; SWEDEN;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SPIROMETRY; SWEDEN; TOBACCO SMOKE POLLUTION;

EID: 84901821562     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-1349     Document Type: Article

References (33)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-2128.
2. Soriano JB, Rodríguez-Roisin R. Chronic obstructive pulmonary disease overview: epidemiology, risk factors, and clinical presentation. Proc Am Thorac Soc. 2011;8(4):363-367.
3. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733-743.
4. Heidrich J, Wellmann J, Heuschmann PU, Kraywinkel K, Keil U. Mortality and morbidity from coronary heart disease attributable to passive smoking. Eur Heart J. 2007;28(20):2498-2502. (Pubitemid 47614272)
5. Bjerg-Bäcklund A, Perzanowski MS, Platts-Mills T, Sandström T, Lundbäck B, Rönmark E. Asthma during the primary school ages - prevalence, remission and the impact of allergic sensitization. Allergy. 2006;61(5):549-555.
6. Brennan P, Buffler PA, Reynolds P, et al. Secondhand smoke exposure in adulthood and risk of lung cancer among never smokers: a pooled analysis of two large studies. Int J Cancer. 2004;109(1):125-131. (Pubitemid 38160672)
7. Öberg M, Jaakkola MS, Woodward A, Peruga A, Prüss-Ustün A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet. 2011;377(9760):139-146.
8. Zheng P, Li W, Chapman S, Zhang Z, Gao J, Fu H. Workplace exposure to secondhand smoke and its association with respiratory symptoms - a cross-sectional study among workers in Shanghai. Tob Control. 2011;20(1):58-63.
9. Radon K, Büsching K, Heinrich J, et al. Passive smoking exposure: a risk factor for chronic bronchitis and asthma in adults? Chest. 2002;122(3):1086-1090.
10. Jaakkola MS, Jaakkola JJ. Effects of environmental tobacco smoke on the respiratory health of adults. Scand J Work Environ Health. 2002;28(suppl 2):52-70. (Pubitemid 34591161)
11. Flouris AD, Metsios GS, Carrillo AE, et al. Acute and short-term effects of secondhand smoke on lung function and cytokine production. Am J Respir Crit Care Med. 2009;179(11):1029-1033.
12. Slowik N, Ma S, He J, et al. The effect of secondhand smoke exposure on markers of elastin degradation. Chest. 2011;140(4):946-953.
13. Eisner MD, Balmes J, Katz PP, Trupin L, Yelin EH, Blanc PD. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health. 2005;4(1):7.
14. Enstrom JE, Kabat GC. Environmental tobacco smoke and tobacco related mortality in a prospective study of Californians, 1960-98. BMJ. 2003;326(7398):1057.
15. Yin P, Jiang CQ, Cheng KK, et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet. 2007;370(9589):751-757. (Pubitemid 47320799)
16. Jordan RE, Cheng KK, Miller MR, Adab P. Passive smoking and chronic obstructive pulmonary disease: cross-sectional analysis of data from the Health Survey for England. BMJ Open. 2011;1(2):e000153.
17. Rabe KF, Hurd S, Anzueto A, et al Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-555. (Pubitemid 47403272)
18. Lundbäck B, Nyström L, Rosenhall L, Stjernberg N. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J. 1991;4(3):257-266.
19. Lindberg A, Jonsson AC, Rönmark E, Lundgren R, Larsson LG, Lundbäck B. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration. 2005;72(5):471-479. (Pubitemid 41433561)
20. Lindström M, Jönsson E, Larsson K, Lundbäck B. Underdiagnosis of chronic obstructive pulmonary disease in Northern Sweden. Int J Tuberc Lung Dis. 2002;6(1):76-84. (Pubitemid 34263549)
21. Gardner RM. Standardization of spirometry: a summary of recommendations from the American Thoracic Society. The 1987 update. Ann Intern Med. 1988;108(2):217-220. (Pubitemid 18081197)
22. Berglund E, Birath G, Bjure J, et al. Spirometric studies in normal subjects. I. Forced expirograms in subjects between 7 and 70 years of age. Acta Med Scand. 1963;173:185-192.
23. Hagstad S, Ekerljung L, Lindberg A, Backman H, Rönmark E, Lundbäck B. COPD among non-smokers-report from the obstructive lung disease in Northern Sweden (OLIN) studies. Respir Med. 2012;106(7):980-988.
24. Bakke PS, Rönmark E, Eagan T, et al European Respiratory Society Task Force. Recommendations for epidemiological studies on COPD. Eur Respir J. 2011;38(6):1261-1277.
25. Hooper R, Burney P, Vollmer WM, et al. Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project. Eur Respir J. 2012;39(6):1343-1353.
26. Lundbäck B, Lindberg A, Lindström M, et al Obstructive Lung Disease in Northern Sweden Studies. Not 15 but 50% of smokers develop COPD? - Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2003;97(2):115-122. (Pubitemid 36284990)
27. Janson C, Chinn S, Jarvis D, Zock JP, Torén K, Burney P; European Community Respiratory Health Survey. Effect of passive smoking on respiratory symptoms, bronchial responsiveness, lung function, and total serum IgE in the European Community Respiratory Health Survey: a cross-sectional study. Lancet. 2001;358(9299):2103-2109. (Pubitemid 34094898)
28. Centers for Disease Control and Prevention. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2006.
29. Radon K, Goldberg M, Becklake M. Healthy worker effect in cohort studies on chronic bronchitis. Scand J Work Environ Health. 2002;28(5):328-332. (Pubitemid 35276844)
30. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2011: Warning About the Dangers of Tobacco. Geneva, Switzerland: World Health Organization; 2011.
31. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Mørkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J. 2002;20(5):1117-1122. (Pubitemid 35331867)
32. Lötvall J, Ekerljung L, Rönmark EP, et al. West Sweden Asthma Study: prevalence trends over the last 18 years argues no recent increase in asthma. Respir Res. 2009;10:94.
33. Silva GE, Sherrill DL, Guerra S, Barbee RA. Asthma as a risk factor for COPD in a longitudinal study. Chest. 2004;126(1):59-65. (Pubitemid 38943118)